Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulating proteins
Authors: Michal Dwojak, Malgorzata Bobrowicz, Jacek Bil, Kamil Bojarczuk, Beata Pyrzynska, Marta Siernicka, Agata Malenda, Ewa Lech-Maranda, Waldemar Tomczak, Krzysztof Giannopoulos, Jakub Golab, Magdalena Winiarska
Published in: Blood Cancer Journal
Publication type: article
Subject areas: Medicine
SJR best quartile: Q1